US-China Collab to Deliver Multiplexed Solutions for mRNA Vaccine and Cell & Gene Therapy
US-China collaboration to deliver multiplexed solutions for mRNA vaccine and cell & gene therapy
Overview
Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields US-based InDevR, Inc., a leading provider of analytical tools for vaccine quality control and testing, has teamed up with Sino Biological, Inc., a biotechnological firm listed on the Shenzhen stock exchange, which specialises in biological research reagents and related technical services.
Aim for This Partnership
This partnership aims to speed up the development of multiplex assays for a variety of applications in vaccine production, mRNA therapies, and cell and gene therapy.
Post Collaboration
As part of the collaboration, Sino Biological’s comprehensive range of high-quality antibodies, antigens, and other reagents will be made available for use on InDevR’s VaxArray Platform.
This platform is widely used by biopharmaceutical companies globally for its ability to perform multiplex assays, which help simplify, standardise, and accelerate the development, optimisation, and scaling of new vaccine formulations.
The alliance intends to develop advanced analytical tools to support breakthroughs in mRNA vaccine technology, vaccine development, and the fast-growing field of cell and gene therapy.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!